In vitro silencing of the IGF-1R suppresses MRP-2 in CRC cells, thereby increasing the intracellular drug concentration of 5-Fluorouracil, Mitomycin C, Oxaliplatin, and Vincristine. The gene discussed is IGF1R; the disease is colorectal carcinoma.